Prevalence and Pattern of Cardiovascular Symptoms and Diseases in Elderly Patients
DOI:
https://doi.org/10.59675/M217Keywords:
Prevalence, Cardiovascular, Symptoms, Diseases, Elderly Patients.Abstract
For men and women of all ages, heart disease continues to be the primary cause of death. Emphasising the necessity of creative methods to improve patient care and survival. Between 50% and 75% of cardiovascular disease-related deaths in wealthy nations happen outside of hospitals. Even in most countries, the proportion of persons over 66 steadily rises and makes up a larger population share. The medical treatment of older people heavily burdens the healthcare system. Giving older patients the proper medical treatment requires specialised understanding. As we age, the body undergoes several changes, and numerous chronic illnesses arise. The visceral organs' function deteriorates, the healing process slows, disease symptoms become less noticeable, and diagnosing a condition is frequently challenging. Furthermore, because the pharmacokinetics and pharmacodynamics of medications vary from those of younger individuals, the therapy options also vary. Having a family member or caregiver participate in the session can be helpful because communicating with elderly individuals can be distressing. For those over 65, "cardiovascular diseases" continue to be the direct reason for death. The most significant of these conditions are atrial "fibrillation", "hypertension", "coronary artery disease", and "congestive heart failure”.
References
Laslett LJ, Alagona P, Clark BA, Drozda JP, Saldivar F, Wilson SR, Poe C, Hart M. The worldwide environment of cardiovascular disease: prevalence, diagnosis, therapy, and policy issues: a report from the American College of Cardiology. Journal of the American College of Cardiology. 2012 Dec 25;60(25S): S1-49.
Sabra AA, Taha AZ, Al-Sebiany AM, Al-Kurashi NY, Al-Zubier AG. Coronary heart disease risk factors: prevalence and behavior among male university students in Dammam City, Saudi Arabia. J Egypt public health Assoc. 2007 Feb 1;82(1-2):21-42
Cappuccio FP, Miller MA. Cardiovascular disease and hypertension in sub-Saharan Africa: burden, risk and interventions. Internal and Emergency Medicine. 2016. 11(3):299–305.
Yuan J, Zou XR, Han SP, Cheng H, Wang L, Wang JW, et al. Prevalence and risk factors for cardiovascular disease among chronic kidney disease patients: Results from the Chinese cohort study of chronic kidney disease (C-STRIDE). BMC Nephrology. 2017. 18(1):1–12.
Insights P. Cardiovascular Disease in Chronic Kidney Disease. Circulation. 2021 Mar 16;143(11):1157-72.
Chillo P, Mujuni E. Prevalence and predictors of left ventricular dysfunction among patients with chronic kidney disease attending Muhimbili National Hospital in Tanzania—a cross-sectional study. Research Reports in Clinical Cardiology. 2018 May 21:11-21.
Babua C, Kalyesubula R, Okello E, Kakande B, Sebatta E, Mungoma M, Mondo C. Pattern and presentation of cardiac diseases among patients with chronic kidney disease attending a national referral hospital in Uganda: a cross sectional study. BMC nephrology. 2015 Dec;16:1-6.
House AA, Wanner C, Sarnak MJ, Piña IL, McIntyre CW, Komenda P, Kasiske BL, Deswal A, DeFilippi CR, Cleland JG, Anker SD. Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney international. 2019 Jun 1;95(6):1304-17.
Meremo AJ, Mwashambwa MY, Masalu MB, Kapinga J, Tagalile R, Ngilangwa DP, Sabi I. Prevalence and predictors of anaemia among patients presenting with kidney diseases at the University of Dodoma Hospital in central Tanzania. Tanzania Journal of Health Research. 2017 Jun 28;19(3).
American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes care. 2010 Jan 1;33(Supplement_1):S62-9.
Gibore NS, Munyogwa MJ, Ng’weshemi SK, Gesase AP. Effect of community-based lifestyle education intervention to reduce cardiovascular diseases risk factors among vulnerable population in Dodoma city, Tanzania: a cluster randomized controlled trial study protocol. Biology Methods and Protocols. 2021 Jan 1;6(1):bpab019.
Fraser SD, Blakeman T. Chronic kidney disease: identification and management in primary care. Pragmatic and observational research. 2016 Aug 17:21-32.
Matsha TE, Erasmus RT. Chronic kidney disease in sub-Saharan Africa. The Lancet Global Health. 2019 Dec 1;7(12):e1587-8.
Saad M, Karam B, Faddoul G, Douaihy YE, Yacoub H, Baydoun H, Boumitri C, Barakat I, Saifan C, El-Charabaty E, Sayegh SE. Is kidney function affecting the management of myocardial infarction? A retrospective cohort study in patients with normal kidney function, chronic kidney disease stage III–V, and ESRD. International journal of nephrology and renovascular disease. 2016 Jan 22:5-10.
Ali S, Dave N, Virani SS, Navaneethan SD. Primary and secondary prevention of cardiovascular disease in patients with chronic kidney disease. Current Atherosclerosis Reports. 2019 Sep;21:1-9.
Agarwal R, Sinha AD, Cramer AE, Balmes-Fenwick M, Dickinson JH, Ouyang F, Tu W. Chlorthalidone for hypertension in advanced chronic kidney disease. New England Journal of Medicine. 2021 Dec 30;385(27):2507-19.
Gaziano TA, Bitton A, Anand S, Abrahams-Gessel S, Murphy A. Growing epidemic of coronary heart disease in low-and middle-income countries. Current problems in cardiology. 2010 Feb 1;35(2):72-115.
Yusuf S, Rangarajan S, Teo K, Islam S, Li W, Liu L, Bo J, Lou Q, Lu F, Liu T, Yu L. Cardiovascular risk and events in 17 low-, middle-, and high-income countries. New England Journal of Medicine. 2014 Aug 28;371(9):818-27.
Teo KK, Dokainish H. The emerging epidemic of cardiovascular risk factors and atherosclerotic disease in developing countries. Canadian Journal of Cardiology. 2017 Mar 1;33(3):358-65.
Tombor I, Paksi B, Urbán R, Kun B, Arnold P, Rózsa S, Berkes T, Demetrovics Z. Epidemiology of smoking in the Hungarian population, based on national representative data. Clinical and Experimental Medical Journal. 2011 Mar 1;5(1):27-37.
Kočanová D, Kováč V, Buleca J. Differences and Similarities in Patterns of Society Ageing in the European Union. Available at SSRN 3973814. 2021.
Hazra NC, Rudisill C, Gulliford MC. Determinants of health care costs in the senior elderly: age, comorbidity, impairment, or proximity to death?. The European journal of health economics. 2018 Jul;19(6):831-42.
Qu C, Liao S, Zhang J, Cao H, Zhang H, Zhang N, Yan L, Cui G, Luo P, Zhang Q, Cheng Q. Burden of cardiovascular disease among elderly: based on the Global Burden of Disease Study 2019. European Heart Journal-Quality of Care and Clinical Outcomes. 2024 Mar;10(2):143-53.
National Research Council, Division of Behavioral, Social Sciences, Committee on National Statistics, Committee on Population, Panel on a Research Agenda, New Data for an Aging World. Preparing for an aging world: The case for cross-national research.
Lye M, Donnellan C. Heart disease in the elderly. Heart. 2000 Nov 1;84(5):560-6.
Strait JB, Lakatta EG. Aging-associated cardiovascular changes and their relationship to heart failure. Heart failure clinics. 2012 Jan 1;8(1):143-64.
Tasić I, Kostić S, Stojanović NM, Djordjević D, Bogdanović D, Deljanin Ilić M, Lović M, Stoičkov V, Aleksandrić S. Predictors of cardiovascular events in hypertensive patients with high cardiovascular risk. Medicina. 2020 Apr 16;56(4):182.
Mills KT, Bundy JD, Kelly TN, Reed JE, Kearney PM, Reynolds K, Chen J, He J. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016 Aug 9;134(6):441-50.
Vishram JK, Borglykke A, Andreasen AH, Jeppesen J, Ibsen H, Jørgensen T, Broda G, Palmieri L, Giampaoli S, Donfrancesco C, Kee F. Impact of age on the importance of systolic and diastolic blood pressures for stroke risk: the MOnica, Risk, Genetics, Archiving, and Monograph (MORGAM) Project. Hypertension. 2012 Nov;60(5):1117-23.
Brown DW, Giles WH, Greenlund KJ. Blood pressure parameters and risk of fatal stroke, NHANES II mortality study. American journal of hypertension. 2007 Mar 1;20(3):338-41.
Gueyffier F. Blood pressure and cardiovascular disease in the Asia Pacific Region. Commentary. Journal of hypertension. 2003;21(4):673-5.
Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999 Jul 27;100(4):354-60.
Domanski M, Mitchell G, Pfeffer M, Neaton JD, Norman J, Svendsen K, Grimm R, Cohen J, Stamler J, MRFIT Research Group, MRFIT Research Group. Pulse pressure and cardiovascular disease–related mortality: follow-up study of the Multiple Risk Factor Intervention Trial (MRFIT). Jama. 2002 May 22;287(20):2677-83.
Majnarić LT, Bosnić Z, Kurevija T, Wittlinger T. Cardiovascular risk and aging: the need for a more comprehensive understanding. Journal of Geriatric Cardiology: JGC. 2021 Jun 6;18(6):462.
Marengoni A, Angleman S, Meinow B, Santoni G, Mangialasche F, Rizzuto D, Fastbom J, Melis R, Parker M, Johnell K, Fratiglioni L. Coexisting chronic conditions in the older population: Variation by health indicators. European journal of internal medicine. 2016 Jun 1;31:29-34.
St Sauver JL, Boyd CM, Grossardt BR, Bobo WV, Rutten LJ, Roger VL, Ebbert JO, Therneau TM, Yawn BP, Rocca WA. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ open. 2015 Feb 1;5(2):e006413.
Bussche HV, Koller D, Kolonko T, Hansen H, Wegscheider K, Glaeske G, Leitner EV, Schäfer I, Schön G. Which chronic diseases and disease combinations are specific to multimorbidity in the elderly? Results of a claims data based cross-sectional study in Germany.
Weiss CO, Boyd CM, Yu Q, Wolff JL, Leff B. Patterns of prevalent major chronic disease among older adults in the United States. Jama. 2007 Sep 12;298(10):1158-62.
Midão L, Giardini A, Menditto E, Kardas P, Costa E. Polypharmacy prevalence among older adults based on the survey of health, ageing and retirement in Europe. Archives of gerontology and geriatrics. 2018 Sep 1;78:213-20.
Inouye SK, Studenski S, Tinetti ME, Kuchel GA. Geriatric Syndromes: Clinical, Research, and Policy Implications of a Core Geriatric Concept: (See Editorial Comments by Dr. William Hazzard on pp 794–796). Journal of the American Geriatrics Society. 2007 May;55(5):780-91.
Clegg A, Young J, Iliffe S, Rikkert MO, Rockwood K. Frailty in elderly people. The lancet. 2013 Mar 2;381(9868):752-62.
Visseren, F.L., Mach, F., Smulders, Y.M., Carballo, D., Koskinas, K.C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.M., Capodanno, D. and Cosyns, B., 2021. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for Cardiovascular Disease Prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC). European heart journal, 42(34), pp.3227-3337.
Paneni F, Diaz Cañestro C, Libby P, Lüscher TF, Camici GG. The aging cardiovascular system: understanding it at the cellular and clinical levels. Journal of the American College of Cardiology. 2017 Apr 18;69(15):1952-67.
Hochman JS, Tamis JE, Thompson TD, Weaver WD, White HD, Van de Werf F, Aylward P, Topol EJ, Califf RM. Sex, clinical presentation, and outcome in patients with acute coronary syndromes. New England Journal of Medicine. 1999 Jul 22;341(4):226-32.
Vaccarino V, Parsons L, Every NR, Barron HV, Krumholz HM. Sex-based differences in early mortalityafter myocardial infarction. N Engl J Med 1999;341:217-25.
Canto JG, Kiefe CI, Rogers WJ, Peterson ED, Frederick PD, French WJ, Gibson CM, Pollack CV, Ornato JP, Zalenski RJ, Penney J. Number of coronary heart disease risk factors and mortality in patients with first myocardial infarction. Jama. 2011 Nov 16;306(19):2120-7.
Farage MA, Miller KW, Ajayi F, Hutchins D. Design principles to accommodate older adults. Global journal of health science. 2012 Mar;4(2):2.
Oh SW. Obesity and metabolic syndrome in Korea. Diabetes & metabolism journal. 2011 Dec;35(6):561.
Forman DE, Alexander K, Brindis RG, Curtis AB, Maurer M, Rich MW, Sperling L, Wenger NK. Improved cardiovascular disease outcomes in older adults. F1000Research. 2016;5.
Nuri MM, Nawaz A, Usman H. A PROPOSED STUDY OF RISK FACTORS OF HEART DISEASE IN RURAL POPULATION OF PUNJAB (PAKISTAN)—TIME TO ACT!. Pakistan Heart Journal. 2006;39(3-4).
Muhammad R, Masood A, Zaffar J, Butt U. Correlation of mean HbA1c levels with severity of coronary arteries disease in diabetics. Pakistan Heart Journal. 2014;47(4).
Anker SD, Berne C, Cosentino F, Danchin N, Deaton C, Escaned J, Hammes HP, Huikuri H, Marre M, Marx N, Mellbin L. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. European Heart Journal. 2013;34:3035-87.
Sharma S. Hypertension with special reference to causes and diet. Indian Journal Of Applied Research. 2015;5:12.
Quiat D, Olson EN. MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment. The Journal of clinical investigation. 2013 Jan 2;123(1):11-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Academic International Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution 4.0 International License.
